Neurometrix Focuses on Diabetes-Related Nerve Damage
President and CEO, Dr. Shai Gozani is interviewed by OneMedRadio where he discusses the Sensus Pain Therapy device.
neurometrix
NeuroMetrix Files 510(k) for SENSUS(TM) Pain Therapy Device
NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes has filed a 510(k), with the FDA for its SENSUS Pain Therapy device.